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Running Title: 
The ROLO Study – Maternal Outcomes at the 5 Year Follow-up 
 
Abstract 
Objective: To determine if a dietary intervention in pregnancy had a lasting effect on 
maternal outcomes of diet, HbA1c and weight retention 5 years’ post-intervention; and to 
establish if modifiable maternal behaviours were associated with these outcomes. 
 
Design: Randomised control trial of low glycaemic index (GI) diet in pregnancy with 
longitudinal follow-up to 5 years’ post-intervention. 
 
Setting: Dublin, Ireland (2007 – 2016) 
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Population: 403 of 759 (53.1%) were followed-up at 5 years. 370 (intervention n=188; 
control n=182) were included in this analysis. 
Methods: Fasting glucose was measured at 13 and 28 weeks’ gestation and HbA1c 
(mmol/mol) at 5-year follow-up. Weight retention (kg) from early-pregnancy to 5 years’ post-
intervention was calculated. Dietary intakes, anthropometry and lifestyle factors were 
measured in pregnancy and 5 years’ post-intervention. Multiple linear regression models, 
controlling for confounders, were used for analysis. 
 
Outcome: Maternal diet, HbA1c and weight retention at 5 years’ post-intervention. 
 
Results: There was no difference between the intervention and control at 5 years’ post-
intervention for any long-term maternal outcomes measured. HbA1c at 5 years’ post-
intervention was associated with early-pregnancy fasting glucose (B:1.70; CI:0.36–3.04) and 
parity ≥3 (B:1.04; CI:0.09–1.99). Weight retention was associated with change in well-being 
from pregnancy to 5 years (B:-0.06; CI:-0.11–-0.02)), gestational weight gain (B:0.19; 
CI:0.00–0.38) and GI (B:0.26; CI:0.06–0.46) at 5 years. 
 
Conclusions 
The ROLO low-GI dietary intervention in pregnancy had no impact on maternal dietary 
intakes, HbA1c or body composition 5 years’ post-intervention. Maternal factors and lifestyle 
behaviours in pregnancy have long-term effects on glucose metabolism and weight retention 
up to 5 years later. 
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Tweetable Abstract 
Pregnancy factors are associated with maternal glucose metabolism & weight retention 5 
years later – findings from the ROLO Study. 
 
Introduction 
The low glycaemic index (GI) diet in pregnancy is associated with improvements in dietary 
intakes 1–3, reduced gestational weight gain (GWG) 1,3, and improved glycaemic response 4. 
While much research has explored offspring outcomes relating to dietary intakes and GI in 
pregnancy 5–9, there is a paucity of research relating to long-term maternal outcomes 
following a low-GI diet in pregnancy. Long-term follow-up of pregnancy intervention studies 
is required to develop an understanding of the impact of maternal diet during a key life stage 
on future health, and  to assess whether lifestyle behaviours are sustained in the postpartum 
period after the intervention has ended. 
Furthermore, the increased physiological demands of pregnancy can act as a biological 
stress test for life to predict a woman’s future health 10. Pregnancy is considered a 
“diabetogenic state” of insulin resistance, exposure to which may result in long-term 
alterations of normal glucose metabolism 11. Gestational diabetes (GDM) increases the risk 
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of type 2 diabetes in later life 12–15, and fasting glucose below levels used to diagnose GDM 
are associated with increased adverse maternal outcomes 16. It is unclear, however, if a 
continuum of increasing fasting blood glucose in pregnancy, below that diagnostic of GDM, 
increases maternal risk of future diabetes. In addition, weight retention in the period after 
pregnancy is associated with increased risk of future obesity 17,18. Examining the modifiable 
behaviours that facilitate or hinder weight loss in the years after pregnancy could assist 
health care professionals to target specific maternal behaviours 19. 
Whether the immediate and lasting effects of pregnancy on a woman’s metabolic health and 
body composition can be influenced through dietary or environmental manipulation is 
pertinent for all women, but requires further study. The ROLO study was a randomised 
control trial (RCT) of a low-GI diet in pregnancy that resulted in improved diet, less GWG 
and improved glucose tolerance 1. Due to the longitudinal nature of the ROLO study follow-
up, with data collected from 13 weeks’ gestation to 5 years’ post-intervention, the findings 
may be used to fill some of the knowledge gaps relating to mothers’ health in the years 
following a dietary intervention.  
We aimed to determine if a low-GI dietary intervention had a lasting effect on maternal diet, 
HbA1c and weight retention 5 years’ post-intervention, and to establish if modifiable 
maternal behaviours, diet and lifestyle factors, in pregnancy and 5 years later were 
associated with HbA1c and weight retention 5 years’ post-intervention. 
Methods 
Study design  
This is a longitudinal study of 370 women originally recruited as part of the ROLO study 1 at 
The National Maternity Hospital, Dublin, Ireland. In summary, the ROLO study randomised 
800 secundigravida women at approximately 13 weeks’ gestation, who had previously 
delivered a macrosomic infant (>4000 g), to receive either low GI dietary advice or usual 
A
cc
ep
te
d 
A
rt
ic
le
 
© 2018 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology 
published by John Wiley & Sons Ltd on behalf of  Royal College of Obstetricians and 
Gynaecologists. 
care (no dietary advice) 1. The primary outcome was birth weight and secondary outcomes 
were GI, GWG and glucose intolerance 1. Two weeks post-randomisation, at approximately 
15 weeks’ gestation, women assigned to the intervention group attended a 2-hour group 
education session with the research dietitian. Women were taught the principles of healthy 
eating and a low-GI diet in pregnancy. The research dietitian met with intervention subjects 
at 28 and 34 weeks’ gestation for brief reinforcement of the diet. 
At 5 years’ post-intervention, all participants were invited to attend a follow-up visit. To be 
eligible for inclusion participants must have attended the follow-up visit before the child was 
5 years and 6 months of age. Institutional ethical approval and informed, written maternal 
consent were obtained. The study was conducted according to the guidelines laid down in 
the Declaration of Helsinki.  
Of the 759 infants born to study mothers, 403 (53.1%) mother-child dyads were followed-up 
at the 5-year follow-up visit. A discussion of retention rates at the 5-year follow-up was 
previously published 20. Of the 403 women, 370 were included in the analysis for weight 
retention (reasons for exclusion: 17 did not have weight measurement at 5-year follow-up 
and 16 were pregnant at time of 5-year follow-up). Of the 370 included, 188 were originally 
randomised to the intervention group and 182 to the control group. For analysis of HbA1c, 
161 were included (reasons for exclusion: 241 did not have a blood sample available for 
HbA1c measurement and 1 had poorly controlled type 2 diabetes that was diagnosed 
postpartum. 
 
Patient Involvement 
In February 2018, the researchers met with the ROLO Family Advisory Committee, a self-
selected group of mothers who are involved in the longitudinal follow-up of the ROLO Study. 
The central theme of this meeting was to discuss key outcomes of importance for the 
A
cc
ep
te
d 
A
rt
ic
le
 
© 2018 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology 
published by John Wiley & Sons Ltd on behalf of  Royal College of Obstetricians and 
Gynaecologists. 
mothers relating to their own health and their children’s health. A report of this meeting is 
being written for publication at present, but in brief, the mothers had greater concern for 
outcomes relating to their children than themselves. In terms of maternal health, weight gain 
during pregnancy and postpartum was not prioritised, however a general blood test in 
pregnancy, that could predict health risks in later life, was viewed positively and welcomed 
by the women.  
 
Core Outcome Sets  
A core outcome set for longitudinal follow-up of mothers postpartum does not exist. 
However, the core outcome sets for diabetes in pregnancy 21 were consulted when deciding 
on the outcomes to examine. The primary reason that HbA1c, weight retention and dietary 
intakes were chosen as outcomes for this piece of research is due to their placement as 
secondary outcomes in the original RCT (infant macrosomia was the primary outcome of the 
RCT) 1.  
 
Data collection 
Anthropometry and body composition 
Height and weight were measured in early pregnancy (13 weeks’ gestation) and at the 5-
year follow-up visit. Body mass index (BMI) (kg/m2) was calculated. Weight retention was 
defined as the difference between weight at the early pregnancy visit and weight at the 5-
year follow-up visit. GWG was calculated by subtracting the measured weight at the first 
antenatal visit from the final weight in pregnancy (measured at 38, 40 or 41 week’s 
gestation). The 2009 Institute of Medicine (IOM) guidelines for total GWG 22 were used to 
categorise GWG. Bioimpedance analysis (BIA) was used to measure fat-free mass and fat 
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mass at the 5-year follow-up visit using the ImpediMed Imp™ SFB7 device (ImpediMed Ltd, 
Brisbane, Australia).  
 
Dietary intakes 
Dietary intakes in pregnancy were collected using 3-day food diaries. All food and beverages 
consumed over three consecutive days were recorded by participants during each trimester. 
To estimate habitual dietary intakes over the previous year, participants completed the 2002 
SLÁN 148-item food frequency questionnaire (FFQ), plus questions relating to milk 23. The 
questionnaire was validated in an Irish population 24 and in pregnancy 25. Dietary data were 
entered into dietary analysis software NetWISP version 3.0 (Tinuviel Software, Llanfechell, 
Anglesey, UK). The NetWISP food composition database was derived from the 6th edition of 
McCance and Widdowson’s food composition tables 26.  
At the 5-year follow-up, participants completed the 2007 SLÁN 150-item FFQ to estimate 
dietary intakes over the past two years 27. The questionnaire was validated in an Irish 
population 27. Standard food portions were assigned to each food item according to the Food 
Standards Agency portion sizes book 28. The nutrient profile for each food item was set using 
data from using the updated 2015 McCance and Widdowson’s The Composition of Foods 
Integrated Dataset 29. 
 
Demographics and lifestyle 
Data were collected on maternal age, parity, number of years since last pregnancy, 
breastfeeding for the study child, maternal educational attainment and smoking. The World 
Health Organisation-5 (WHO-5) well-being index was used to assess well-being in 
pregnancy and at the 5-year visit 30. Physical activity was assessed in pregnancy using the 
1998 SLÁN questionnaire, which was based on the Godin Leisure-Time Exercise 
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Questionnaire 31. At the 5-year follow-up visit, participants completed the short International 
Physical Activity Questionnaire (IPAQ) 32. Metabolic equivalents (METs) were calculated 33, 
and participants were classified as low, medium or high. Minutes spent walking was 
recorded at both time points.  
Blood sample 
At 13 and 28 weeks’ gestation, fasting blood samples were collected. A glucose challenge 
test (GCT), 1-hour post a 50 g glucose load, was performed at 28 weeks’ gestation. Glucose 
intolerance in pregnancy was classified as 28 weeks’ gestation fasting glucose ≥5.1 mmol/L 
or 28 weeks’ gestation GCT >7.8 mmol/L., as previously used in the ROLO Study 1. Fasting 
glucose results were also categorised according to the HAPO glucose categories 16. At the 
5-year follow-up visit a non-fasting blood sample was collected and HbA1c concentration 
was determined using Tina-quant HemoglobinA1c Generation 3, analysed on a Roche 
Cobas 6000 (Roche Diagnostics GmbH, Mannheim, Germany).  
 
Statistical Analysis 
Data were assessed for normality using the Kolmogorov-Smirnov test and visual inspection 
of histograms. Non-normally distributed variables were log transformed for regression 
analysis. We included the maximum number of participants with complete data for each set 
of analysis. Correlations between maternal characteristics and HbA1c and weight change 
were initially examined. Bivariate associations with significance of P < 0.1 were further 
analysed using multiple regression models. Models were created using a forced-enter 
approach and were adjusted for confounders. Confounders were chosen a priori, based on 
the literature and correlations observed in the data. Models exploring HbA1c as an outcome 
were controlled for grouping (intervention), maternal age at the 5-year follow-up, BMI at the 
5-year follow-up, ethnicity, energy (kcal/day) at the 5-year follow-up and physical activity 
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(IPAQ) at the 5-year follow-up. Models exploring weight retention as an outcome were 
controlled for grouping (intervention), maternal education, parity, smoking status at 5 years, 
energy (kcal/day) at the 5-year follow-up, physical activity (IPAQ) at the 5-year follow-up and 
GWG. The model testing GWG as an independent variable was additionally controlled for 
early-pregnancy BMI. To improve interpretation of the results, the variables for energy were 
scaled (per 100 kcal/day) for the multiple linear regression analysis. 
 
Funding 
This study was supported by the Health Research Centre for Health and Diet Research 
(Health Research Board Ireland), The National Maternity Hospital Medical Fund and the 
European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition 
under grant agreement no. 289346. The funding sources had no involvement in the study. 
 
Results 
Maternal Characteristics and Dietary Intakes 
Half (n = 188 [50.8%]) of the women who attended the 5-year follow-up ROLO study visit 
had been originally randomised to the intervention group of the ROLO RCT and 182 (50.2%) 
to the control group. Maternal characteristics are detailed in Table 1. Weight remained 
generally stable from early pregnancy (mean [SD]: 72.0 [12.9] kg) to 5-years’ post-
intervention (mean [SD]: 71.8 [13.5] kg), with mean (SD) postpartum weight retention of -0.1 
(6.1) kg (Table 1). Substantial weight retention of ≥5 kg was observed in 59 (16.1%) women. 
At the 5-year follow-up, mean (SD) HbA1c was 31.46 (2.70) mmol/mol and 5.03 (0.25) % 
(Table 1). Two women had a HbA1c concentration between 39 – 47 mmol/mol, classified as 
pre-diabetes according to the American Diabetes Association guidelines 34. Dietary GI was 
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similar between the food diaries in pregnancy and the FFQ instrument completed at the 5-
year follow-up visit (mean [SD] in trimester 3: 56.75 [3.96] and 56.11 [3.82], respectively).  
 
Among those who attended the 5-year follow-up, no significant differences between the 
intervention and control groups existed in terms of GWG, excessive GWG as per the IOM 
guidelines, BMI at 5 years, weight retention, glucose metabolism in pregnancy and HbA1c at 
5 years (Table 2). Based on the three-day food diaries completed in pregnancy, GI, 
glycaemic load (product of GI and carbohydrate intake), carbohydrate (g/day) and sugar (g) 
were similar between the intervention and control in trimester 1 (pre-intervention) and were 
significantly lower in the intervention group in trimester 2 and 3 (post-intervention). In all 
trimesters of pregnancy the intervention group reported consuming significantly less energy 
(kcal/day) and greater percentage energy from protein (Table 2, S1 and S2). However, the 
FFQ completed at the 5 years’ post-intervention did not detect differences in GI nor any 
other dietary intakes between the intervention and control group (Table 2, S1 and S2). 
 
HbA1c at 5 Years 
The positive correlation between fasting glucose in pregnancy (categorised as per the HAPO 
study) and HbA1c at 5 years’ post-intervention is described in Figure S1 of supporting 
information.  
On multiple linear regression, controlling for confounders, a 1 mmol/L increase in early-
pregnancy fasting glucose was associated with a 1.70 (95% CI: 0.36 - 3.04) mmol/mol 
increase in HbA1c; a one-category increase in HAPO glucose categories in early pregnancy 
was associated with a 0.53 (95% CI: 0.16 - 0.90) mmol/L increase in HbA1c; and a trend 
was observed (P = 0.050) for an association between glucose intolerance at 28 weeks’ 
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gestation and a 1.06 (95% CI: 0.00 - 2.12) mmol/mol increase in HbA1c (Table 3). Each 
additional child, after the index study child (second child), was associated with a 0.83 (95% 
CI: 0.11 - 1.55) mmol/mol increase in HbA1c at the 5-year visit, and having 3 or more 
children was associated with a 1.04 (95% CI: 0.09 - 1.99) mmol/mol higher HbA1c at the 5-
year visit than those with 2 children (Table 3). 
Weight Retention  
On multiple linear regression, controlling for confounders, a 1 percentage score increase in 
well-being from pregnancy to the 5-year visit was associated with 0.06 (95% CI: 0.02 - 0.11) 
kg less weight retention; a 1 kg increase in GWG was associated with 0.19 (95% CI: 0.00 - 
0.38) kg higher weight retention (additionally controlling for early-pregnancy BMI); a 1 
percentage increase in energy from protein at 5-year visit was associated with 0.30 (95% CI: 
0.03 - 0.56) kg less weight retention; and 1 unit increases in GI and glycaemic load at the 5-
year visit were associated with higher weight retention (0.26 [95% CI: 0.06 - 0.46] and 0.04 
[95% CI: 0.01 - 0.07] kg, respectively) (Table 4). Weight retention was positively associated 
with BMI (B = 0.38; 95% CI: 0.21 - 0.56) and fat mass (B = 0.22; 95% CI: 0.10 - 0.33) at the 
5-year visit (Table 4). 
 
Lost to Follow-up 
Compared to women who were lost to follow-up, those who attended the 5-year visit were 
significantly older in pregnancy (mean [SD]: 31.74 [4.42] vs. 33.08 [3.92], P <0.001), more 
likely to have completed tertiary education (48.7% vs. 61.1%, P = 0.003), had a lower early-
pregnancy BMI (kg/m2) (mean [SD]: 27.38 [5.35] vs. 26.10 [4.44], P <0.001) and higher 
early-pregnancy fasting glucose (mmol/L) (mean [SD]: 4.42 [0.38] vs. 4.49 [0.36], P = 0.015) 
(Table S1). No significant differences were observed in randomisation grouping, GWG or 
well-being (Table S1). Women who attended the 5-year follow-up visit reported higher 
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energy intakes throughout pregnancy, but no other nutrients were consistently different 
between those who attended and those lost to follow-up (Table S3). 
 
Discussion 
Main Findings 
This was the 5-year longitudinal follow-up of women who participated in the ROLO RCT of a 
low-GI diet in pregnancy. The intervention and control groups did not differ in any outcomes 
measured at 5 years. Higher fasting glucose in early pregnancy and parity were positively 
associated with HbA1c at the 5-year follow-up. Lower GWG and an improved sense of well-
being over time were associated with less weight retention. Habitual dietary intakes of higher 
energy from protein, lower GI and lower GL in the two years prior to the 5-year follow-up visit 
were also associated with less weight retention.  
 
Strengths and Limitations 
The longitudinal nature of the ROLO study and the well-characterised cohort provide novel 
findings relating to mothers’ metabolism and body composition in the years following a 
dietary intervention. Strengths of this study include the objective measurement of 
anthropometry by trained researchers and the prospective collection of detailed dietary and 
biochemical data at multiple time points. In terms of generalisability, it is probable that our 
findings are not applicable to populations other than educated, Caucasian women living in a 
developed county. Furthermore, all women had previously delivered a macrosomic infant. In 
total, 53.1% (403/759) of the ROLO study participants completed the 5-year follow-up. This 
is not dissimilar to the follow-up rates of similar research studies; at 6-months postpartum 
the UPBEAT study followed-up 45.9% 6; at 12 months postpartum the PIN study followed-up 
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47.0% 35; and at 3 – 6 years Project Viva followed-up 68.1% 36. The differences in maternal 
characteristics between those who attended and lost-to-follow-up are discussed above and 
must be considered when interpreting these findings. Weight remained generally stable from 
early pregnancy to 5-years’ post-intervention which is less than that quoted in the literature 
for 3 years’ (2.2 kg) 37 and 7 years’ (2.1 kg)17 post-partum. It is possible that those who were 
not followed-up had greater weight retention. In terms of statistical analysis, some of the R2 
adjusted in the multiple linear regression models are approaching zero or are negative, 
meaning that these models have low predictive power. Adjustment of the significance level 
for multiple testing was not used, increasing the risk of observing a chance finding. Finally, 
due to the observational nature of this study, we cannot infer causality based on these 
findings. 
 
Interpretation 
HbA1c at 5 Years 
We observed that increasing early-pregnancy fasting glucose and HAPO glucose categories 
were positively associated with HbA1c 5 years later. Both the HAPO study and a recent 
systematic review by Farrar et al. reported that a linear relationship exists between glucose 
concentration in pregnancy and adverse perinatal outcomes, with no obvious threshold 
observed above which risk of adverse outcomes are substantially increased 16,38. It could be 
hypothesised that a continuum of increasing fasting blood glucose in pregnancy potentially 
poses longer term risks than those outlined by the aforementioned studies. In our study, a 
trend was observed between glucose intolerance (using a 50 g GCT) at 28 weeks’ gestation 
and HbA1c 5 years later (P = 0.050). Our findings are supported by previous research that 
indicated an abnormal GCT was associated with lower insulin sensitivity at 3 years 
postpartum 37. These results suggest that subtle variations in fasting glucose and glucose 
tolerance in pregnancy are associated with HbA1c up to 5 years later; however, whether this 
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has a meaningful impact on long-term diabetes risk requires further research. Future 
longitudinal studies may benefit from using a 75 g oral glucose tolerance test in pregnancy, 
the current recommended test for diagnosis of GDM 39. 
 
Additionally, increasing parity was associated with HbA1c at the 5-year visit, in keeping with 
literature that has observed a greater risk of developing type 2 diabetes as parity increases 
11,40,41. It has been theorised that repeated exposure the “diabetogenic state” of insulin 
resistance, characteristic of pregnancy, may result in long-term alteration of normal glucose 
metabolism 11.  
 
Weight Retention  
Each kilogram increase in GWG was associated with 0.19 kg increase in weight retention at 
5 years’ post-intervention. Similar rates have been quoted in the literature 42,43, while others 
have suggested that first trimester GWG is more strongly associated with postpartum weight 
retention than second or third trimester GWG 43. It would seem prudent to offer pregnant 
women lifestyle interventions that reduce GWG. Nevertheless, the ROLO intervention, which 
was successful in reducing GWG, was not associated with weight retention at 5 years’ post-
intervention. Perhaps an intervention that included reinforcement in the postpartum period 
may have been more successful in preventing weight retention.  
 
We observed increased well-being from pregnancy to the 5-year visit was associated 
reduced weight retention. Anxiety in pregnancy, stressful events in the early postpartum 
period and postpartum depression are associated with increased weight retention 35,44,45, 
suggesting that a woman’s mental health is of great importance in terms of weight retention 
in the years following the birth of her children. Optimising well-being through the provision of 
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appropriate support, such as parenting support, stress relief classes, self-management 
strategies and behaviour change could have the potential to alleviate stress and thus, lessen 
weight retention 46. It should also be noted that medications used to treat and manage 
anxiety and mental health conditions may be a confounding factor in the association 
between poor mental health and weight gain. 
Weight retention 5 years’ post-intervention was not associated with being a member of the 
intervention group, dietary GI or glycaemic load in pregnancy. While our findings are similar 
to those of the UPBEAT 6-month follow-up study 6, they are contrary to findings from the 
Danish National Birth Cohort which demonstrated an association between increasing 
glycaemic load in pregnancy and greater weight retention at 18 months’ post-pregnancy 47. 
We did, however, observe that higher GI and glycaemic load reported at the 5-year visit 
(reflective of the previous two years) were positively associated with weight retention. This 
suggests that the glycaemic effect of current dietary intakes is of greater relevance to weight 
status than diet in pregnancy, and also advocates for the potential benefit of reinforcements 
of a low-GI dietary intervention in the postpartum period.  
In terms of sustainability of the ROLO study, the maternal benefits seemed to extend to 3 
and 6 months’ post-intervention, as previously published 48,49, but not up to 5 years’ post-
intervention. These results are broadly similar to what was reported in the previous 
pregnancy RCTs, which have observed short-term (4 – 6 month) 6,7, but not long term (up to 
2 years) 50 maintenance of lifestyle behaviours and health benefits. To be sustainable, 
additional interventions that reinforce dietary changes are likely required in the postpartum 
period 51.  
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Conclusions 
Fasting glucose and GWG in pregnancy are associated with HbA1c and weight retention 5 
years later, adding to the hypothesis that pregnancy is a window to future maternal health. 
The ROLO low-GI dietary intervention in pregnancy did not have a lasting impact on dietary 
intakes, HbA1c or body composition 5 years later; however the value of improving dietary 
intakes in pregnancy and the postpartum years should not be underestimated given the long 
lasting impact that GWG potentially has on future maternal body composition. To maintain 
positive behaviours adopted during pregnancy, it is likely that additional interventions that 
reinforce dietary changes are required postpartum, an area which requires substantial 
research. 
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Table 1. Maternal Characteristics of those who attended the 5-Year ROLO Follow-Up  
Demographics N  
Age at delivery, (years) 
a
 370 33.17 (3.95) 
Age at 5-year follow-up visit, (years)
 a
 370 38.36 (3.96) 
Parity
 a
 370 2.48 (0.64) 
   ≥3 children
 b
  152 (41.08) 
Years since birth of youngest child
 c
 360 5.07 (2.46) 
   ≥2 years
 b
  311 (86.39) 
Education, completed tertiary
 b
 324 199 (61.42) 
Anthropometry   
Weight, early pregnancy, (kg)
 a
 368 71.98 (12.88) 
Weight, final pregnancy, (kg)
 a
 297 84.80 (13.14) 
Weight, 5-year follow-up visit, (kg)
 a
 368 71.82 (13.45) 
Gestational weight gain, (kg)
 a
 296 12.83 (4.23) 
    Inadequate
 b
  62 (20.95) 
    Adequate
 b
  96 (32.43) 
    Excessive
 b
  138 (46.62) 
Weight retention from early pregnancy to 5 years, (kg)
 a
 366 -0.10 (6.05) 
Height, (cm)
 a
 369 165.91 (6.31) 
Early-pregnancy BMI, (kg/m
2
)
 a
 368 26.16 (4.49) 
5-year follow-up visit BMI, (kg/m
2
)
 a
 368 26.04 (4.67) 
Bioelectrical Impedance   
Fat-free mass, 5-year follow-up visit, (kg)
 a
 231 48.47 (7.01) 
Fat-free mass %, 5-year follow-up visit
 a
 231 68.09 (6.77) 
Fat mass, 5-year follow-up visit, (kg)
 a
 231 23.47 (8.50) 
Fat mass %, 5-year follow-up visit
 a
  231 31.86 (6.82) 
Physical Activity     
Pregnancy, walk for at least 30 minutes, (days/week)
 c
 262 3.0 (3.0) 
5-year follow-up visit, total METS
 a
 323 1762.32 (1863.01) 
    High IPAQ
 b
  98 (30.30) 
    Medium IPAQ
 b
  129 (39.90) 
    Low IPAQ
 b
  96 (29.70) 
5-year follow-up visit , walking, (minutes/week)
 a
 323 234.83 (305.19) 
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Glucose Metabolism   
Early pregnancy fasting glucose (mmol/L)
 a
 356 4.50 (0.36) 
28 weeks' gestation fasting glucose (mmol/L)
 a
 347 4.49 (0.46) 
1-hour GCT, 28 weeks' gestation, (mmol/L)
 a
 363 6.55 (1.48) 
Glucose intolerant, 28 weeks' gestation, Yes
 b
 366  92 (25.14) 
HbA1c, 5-year follow-up visit, (%) 
a
 160 5.03 (0.25) 
HbA1c, 5-year follow-up visit, (mmol/mol)
 a
 160 31.46 (2.70) 
Well-Being (WHO-5) Percentage Score     
Pregnancy 
a
 321 58.32 (15.14) 
5-year follow-up visit 
a
 321 62.69 (14.44) 
Change pregnancy to 5-year follow-up visit 
a
   287 4.35 (15.47) 
Breastfeeding Practices     
No breastfeeding
 b
 338 124 (36.70) 
<26 weeks
 b
  116 (34.30) 
≥26 weeks
 b
  98 (29.00) 
Glycaemic  Index   
Trimester 1
 a
 288 57.63 (3.90) 
Trimester 2
 a
 288 56.70 (3.68) 
Trimester 3
 a
 288 56.75 (3.96) 
Mid-pregnancy FFQ
 a
 325 54.50 (3.20) 
5-year follow-up visit
 a
 326 56.11 (3.82) 
Data presented as:
 a 
Mean (SD), 
b
 n (%),
 c
 median (IQR) 
BMI: body mass index;   IPAQ: international physical activity questionnaire; IQR: interquartile range;  
METS: metabolic equivalents; SD: standard deviation; 
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Table 2. Maternal Characteristics at the 5-Year Follow-Up Visit (Intervention vs. 
Control) 
 
Grouping N 
 
P 
Demographics     
Age, 5-year follow-up, (years)
 a
 
Control 182 38.75 (3.87) 0.062 
Intervention 188 37.98 (4.01)  
Weight     
Gestational weight gain, (kg)
 a
 
Control 142 13.27 (4.48) 0.084 
Intervention 154 12.42 (3.96) 
 
Exceed IOM weight gain guidelines
 b
 
Control 142 72 (50.70) 0.200 
Intervention 154 66 (42.86)  
Weight, 5-year follow-up, (kg)
 a
 
Control 182 71.74 (13.86) 0.910 
Intervention 186 71.89 (13.08) 
 
BMI, 5-year follow-up, (kg/m
2
)
 a
 
Control 182 25.98 (4.75) 0.799 
Intervention 186 26.10 (4.60) 
 
Weight Retention from Early Pregnancy to 5 years 
Weight retention, (kg)
 a
 
Control 181 -0.10 (5.94) 0.989 
Intervention 185 -0.09 (6.18) 
 
% weight retention
 a
 
Control 181 -0.06 (7.82) 0.801 
Intervention 185 0.15 (8.00) 
 
Bioelectrical Impedance 
    
Fat-free mass, 5-year follow-up, (kg)
 a
 
Control 117 48.21 (7.05) 0.578 
Intervention 114 48.73 (7.00) 
 
Fat-free mass %, 5-year follow-up
 a
 
Control 117 68.39 (7.06) 0.501 
Intervention 114 67.79 (6.48) 
 
Fat mass, 5-year follow-up, (kg)
 a
 
Control 117 23.15 (9.04) 0.565 
Intervention 114 23.79 (7.94) 
 
Fat mass %, 5-year follow-up
 a
 
Control 117 31.52 (7.15) 0.445 
Intervention 114 32.21 (6.48) 
 
Glucose Metabolism     
Fasting glucose, early pregnancy, (mmol/L)
 a
 
Control 173 4.50 (0.33) 0.952 
Intervention 183 4.50 (0.38)  
Fasting glucose, 28 weeks' gestation, (mmol/L)
 a
 Control 168 4.48 (0.49) 0.699 
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Intervention 179 4.50 (0.44)  
1-hour GCT, 28 weeks' gestation, (mmol/L)
 a
 
Control 177 6.58 (1.48) 0.642 
Intervention 186 6.51 (1.48)  
Glucose intolerant, 28 weeks' gestation
 a
 
Control 178 48 (26.97) 0.506 
Intervention 188 44 (23.40)  
HbA1c, 5-year follow-up, (mmol/mol)
 a
 
Control 82 31.61 (2.95) 0.460 
Intervention 78 31.30 (2.42)  
Glycaemic  Index     
Trimester 1 
a
 
Control 150 57.66 (3.94) 0.894 
Intervention 138 57.60 (3.88)  
Trimester 2 
a
 
Control 150 57.38 (3.42) 0.001 
Intervention 138 55.96 (3.82)  
Trimester 3 
a
 
Control 150 57.39 (3.95) 0.004 
Intervention 138 56.05 (3.87)  
Mid-pregnancy FFQ 
a
 
Control 160 54.63 (3.37) 0.473 
Intervention 166 54.37 (3.03)   
5-year follow-up visit 
a
 
Control 158 55.80 (3.85) 0.156 
Intervention 168 56.40 (3.78)   
Data presented as:
 a
 Mean (SD),
 b 
n (%) 
SD: standard deviation; GCT: glucose challenge test; BMI: body mass index; Glucose intolerant at 28 
weeks’ gestation: fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L 
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Table 3. Multiple Linear Regression Models for Associations between Maternal Characteristics and HbA1c (mmol/mol) 
  N B (%∆) 
a
 P 95% CI R
2
 Adj Model P 
Demographics and Lifestyle             
Parity 136 0.83 0.025 (0.11, 1.55) 0.06 0.029 
   ≥3 children 136 1.04 0.033 (0.09, 1.99) 0.06 0.035 
Years since birth of youngest child 
a
 134 -0.68 (-46.44%) 0.086 (-1.46, 0.10) 0.05 0.065 
Walk for at least 30 minutes in pregnancy, (days/week) 
a
 99 1.20 (232.01%) 0.018 (0.21, 2.18) 0.00 0.398 
Glucose Metabolism             
Fasting glucose, Early pregnancy, (mmol/L) 129 1.70 0.013 (0.36, 3.04) 0.07 0.020 
Fasting glucose, Early pregnancy, HAPO glucose categories 129 0.53 0.006 (0.16, 0.90) 0.09 0.011 
Fasting glucose, Early pregnancy, HAPO glucose categories, >4.4mmol/L 129 0.79 0.106 (-0.17, 1.75) 0.05 0.071 
Fasting glucose, 28 weeks' gestation, (mmol/L) 130 0.91 0.109 (-0.21, 2.03) 0.05 0.054 
Fasting glucose, 28 weeks' gestation, HAPO glucose categories 130 0.34 0.055 (-0.01, 0.69) 0.06 0.036 
1-hour GCT, 28 weeks' gestation, (mmol/L) 132 0.29 0.076 (-0.03, 0.61) 0.06 0.046 
Glucose intolerant, 28 weeks' gestation 133 1.06 0.050 (0.00, 2.12) 0.06 0.039 
Dietary intakes             
Energy             
    Trimester 1, (100 kcal/day) 116 0.16 0.008 (0.04, 0.27) 0.01 0.351 
    Trimester 2, (100 kcal/day) 117 0.16 0.006 (0.04, 0.27) 0.01 0.304 
    Trimester 3, (100 kcal/day) 116 0.13 0.028 (0.01, 0.25) -0.01 0.582 
Protein             
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    Trimester 2, (g/day) 117 0.03 0.021 (0.01, 0.06) -0.01 0.518 
    Trimester 1, (%energy) 116 -0.21 0.014 (-0.38, -0.04) 0.00 0.452 
Fat             
    Trimester 2, (g/day) 117 0.02 0.046 (0.00, 0.04) -0.02 0.684 
    Trimester 3, (g/day) 116 0.02 0.028 (0.00, 0.04) -0.01 0.577 
Carbohydrate             
    Trimester 1, (g/day) 116 0.01 0.003 (0.00, 0.02) 0.02 0.207 
    Trimester 2, (g/day) 117 0.01 0.005 (0.00, 0.02) 0.02 0.261 
    Trimester 3, (g/day) 116 0.01 0.075 (0.00, 0.02) -0.03 0.784 
Glycaemic  Index             
    Trimester 1 112 0.13 0.048 (0.00, 0.25) -0.02 0.628 
Glycaemic  Load             
    Trimester 1 112 0.02 0.002 (0.01, 0.03) 0.04 0.127 
    Trimester 2 112 0.02 0.024 (0.00, 0.03) 0.00 0.489 
    Trimester 3 112 0.01 0.106 (0.00, 0.03) -0.03 0.789 
Sugar             
    Trimester 1, (g/day) 116 0.01 0.021 (0.00, 0.03) -0.01 0.529 
    Trimester 2, (g/day) 117 0.01 0.027 (0.00, 0.03) -0.01 0.567 
Confounders: grouping (intervention), maternal age at the 5-year follow-up, BMI at the 5-year follow-up, ethnicity, energy (kcal) at the 5-year follow-up and physical activity 
(IPAQ) at the 5-year follow-up. 
a
 %∆: percentage change for logged variables (non-normally distributed). GCT: glucose challenge test. Glucose intolerant at 28 weeks’ 
gestation: fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L 
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Table 4. Multiple Linear Regression Models for Associations between Maternal 
Characteristics and Weight Retention (kg) 
 
N B (%∆) 
a
 P 95% CI R
2
 Adj Model P 
Demographi
cs and 
Lifestyle       
Years since 
birth of 
youngest 
child 
a
 
268 
-2.09 (-87.64%) 0.027 (-3.94, -0.24) 0.08 0.001 
Change 
pregnancy to 
5-year Well-
Being (WHO-
5) percentage 
score 
263 
-0.06 0.011 (-0.11, -0.02) 0.07 0.002 
Anthropomet
ry       
Final 
pregnancy 
weight, (kg)  
218 
-0.08 0.015 (-0.14, -0.01) 0.07 0.002 
Gestational 
weight gain, 
(kg) 
218 
0.19 0.049 (0.00, 0.38) 0.08 0.001 
Body Mass 
Index, early 
pregnancy, 
(kg/m
2
) 
270 
-0.25 0.007 (-0.43, -0.07) 0.08 0.001 
Body Mass 
Index, 5-year 
follow-up visit, 
(kg/m
2
)  
270 
0.38 0.000 (0.21, 0.56) 0.13 <0.001 
Fat-free 
mass, 5-year 
follow-up visit, 
(kg) 
168 
0.09 0.186 (-0.05, 0.23) -0.04 0.910 
Fat-free mass 
%, 5-year 
follow-up visit 
168 
-0.25 0.001 (-0.39, -0.11) 0.04 0.099 
Fat mass, 5-
year follow-up 
visit, (kg) 
168 
0.22 0.000 (0.10, 0.33) 0.06 0.048 
Fat mass %, 
5-year follow-
up visit 
168 
0.25 0.001 (0.11, 0.39) 0.04 0.099 
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Glucose 
Metabolism  
     
Fasting 
glucose, 28 
weeks' 
gestation, 
(mmol/L) 
253 -1.39 0.127 (-3.18, 0.40) 0.04 0.038 
Fasting 
glucose, 28 
weeks' 
gestation, 
HAPO 
glucose 
categories 
253 -0.30 0.312 (-0.89, 0.28) 0.04 0.060 
1-hour GCT, 
28 weeks' 
gestation, 
(mmol/L) 
264 -0.64 0.027 (-1.20, -0.07) 0.06 0.006 
Dietary 
intakes  
     
Protein 
 
     
    Trimester 
1, (g/day) 
241 -0.03 0.240 (-0.07, 0.02) 0.04 0.055 
    Trimester 
1, (%energy) 
241 -0.16 0.229 (-0.42, 0.10) 0.04 0.054 
    Trimester 
2, (%energy) 
244 -0.07 0.633 (-0.37, 0.23) 0.03 0.075 
    5-year 
follow-up 
FFQ, 
(%energy) 
270 -0.30 0.027 (-0.56, -0.03) 0.07 0.003 
Carbohydrate 
 
     
    Trimester 
2, (g/day) 
244 0.01 0.225 (-0.01, 0.02) 0.04 0.050 
    Trimester 
1, (%energy) 
241 0.09 0.214 (-0.05, 0.23) 0.04 0.052 
    Trimester 
2, (%energy) 
244 0.04 0.572 (-0.10, 0.19) 0.03 0.073 
    5-year 
follow-up 
FFQ, 
(%energy) 
270 0.11 0.071 (-0.01, 0.23) 0.06 0.006 
Glycaemic  
Index  
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    5-year 
follow-up FFQ 
270 0.26 0.012 (0.06, 0.46) 0.08 0.002 
Glycaemic  
Load  
     
    Trimester 2 230 0.02 0.259 (-0.01, 0.04) 0.03 0.076 
    5-year 
follow-up FFQ 
270 0.04 0.017 (0.01, 0.07) 0.07 0.002 
Sugar 
 
     
    Trimester 
1, (g/day) 
241 0.02 0.139 (-0.01, 0.04) 0.04 0.042 
    Trimester 
2, (g/day) 
244 0.01 0.190 (-0.01, 0.04) 0.04 0.046 
Confounders: grouping (intervention), maternal education, years since birth of youngest child, smoking status at 5 
years, energy (kcal) at the 5-year follow-up, physical activity (IPAQ) at the 5-year follow-up, and GWG. GWG 
model additionally controlled for early-pregnancy BMI. Years since birth of youngest child model additionally 
controlled for parity. 
a 
%∆: percentage change for logged variables (non-normally distributed). GCT: glucose 
challenge test; FFQ: food frequency questionnaire. 5-year follow-up visit FFQ estimated dietary intakes over the 
past two years 
 
 
